Coactivation d’AMPK et de mTORC1

By Tamburini Jérôme   Poulain Laury   Bouscary Didier   Sujobert Pierre  

Médecine/sciences, Vol. 31, Iss. 10, 2015-10 ,pp. : 836-839

Edp Sciences

Access to resources Recommend Favorite

mTORC1 and the regulation of skeletal muscle anabolism and mass

By Adegoke Olasunkanmi A.J.   Abdullahi Abdikarim   Tavajohi-Fini Pegah  

Applied Physiology, Nutrition, and Metabolism, Vol. 37, Iss. 3, 2012-06 ,pp. : 395-406

NRC Research Press

Access to resources Recommend Favorite

O‐18: mTORC1 is a novel HCV host factor

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 11-11

John Wiley & Sons Inc

Access to resources Recommend Favorite

A phase I dose‐escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC‐223 in patients with advanced solid tumors or multiple myeloma

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3481-3490

John Wiley & Sons Inc

Access to resources Recommend Favorite

Interferon-γ Inhibits Nonopsonized Phagocytosis of Macrophages via an mTORC1-c/EBPβ Pathway

By  

Journal of Innate Immunity, Vol. 7, Iss. 2, 2014-09 ,pp. : 165-176

Karger

Access to resources Recommend Favorite